Increased incidence and disparity of diagnosis of retinoblastoma patients in Guatemala

被引:24
作者
Dean, Michael [1 ]
Bendfeldt, Giovana [1 ,2 ]
Lou, Hong [3 ]
Giron, Veronica [4 ,5 ]
Garrido, Claudia [4 ,5 ]
Valverde, Patricia [4 ,5 ]
Barnoya, Margarita [4 ,5 ]
Castellanos, Mauricio [4 ,5 ]
Jimenez-Morales, Silvia [1 ,4 ,6 ]
Luna-Fineman, Sandra [4 ,5 ,7 ]
机构
[1] NCI, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21702 USA
[2] Univ San Carlos, Sch Med, Guatemala City, Guatemala
[3] Leidos Biomed Res Corp, Frederick, MD 21702 USA
[4] Stanford Univ, Stanford, CA 94305 USA
[5] Unidad Nacl Oncol Pediat, Guatemala City, Guatemala
[6] Natl Inst Genom Med, Lab Immunogen & Metab Dis, Mexico City, DF, Mexico
[7] Stanford Univ, Sch Med, Pediat Hematol Oncol SCT Canc Bio, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
RB1; gene; Mutations; Methylation; Guatemala; Ethnicity; Health disparity; RB1; GENE; CANCER; MUTATIONS; HYPERMETHYLATION; ASSOCIATION; EXPRESSION; FREQUENCY; SPECTRUM;
D O I
10.1016/j.canlet.2014.04.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Analysis of 327 consecutive cases at a pediatric referral hospital of Guatemala reveals that retinoblastoma accounts for 9.4% of all cancers and the estimated incidence is 7.0 cases/million children, higher than the United States or Europe. The number of familial cases is low, and there is a striking disparity in indigenous children due to late diagnosis, advanced disease, rapid progression and elevated mortality. Nine germline mutations in 18 patients were found; two known and five new mutations. Hypermethylation of RB1 was identified in 13% of the tumors. An early diagnosis program could identify cases at an earlier age and improve outcome of retinoblastoma in this diverse population. Published by Elsevier Ireland Ltd.
引用
收藏
页码:59 / 63
页数:5
相关论文
共 21 条
  • [1] Abidi O, 2011, MOL VIS, V17, P3541
  • [2] Spectrum of gross deletions and insertions in the RB1 gene in patients with retinoblastoma and association with phenotypic expression
    Albrecht, P
    Ansperger-Rescher, B
    Schüler, A
    Zeschnigk, M
    Gallie, B
    Lohmann, DR
    [J]. HUMAN MUTATION, 2005, 26 (05) : 437 - 445
  • [3] CA M.D.E.G., 2008, INF NAC REP GUAT, P57
  • [4] Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma
    Cohen, Yoram
    Merhavi-Shoharn, Efrat
    Avraharn, Revital B.
    Frenkel, Shahar
    Pe'er, Jacob
    Goldenberg-Cohen, Nitza
    [J]. EXPERIMENTAL EYE RESEARCH, 2008, 86 (02) : 201 - 206
  • [5] Incidence of cancer in children residing in ten jurisdictions of the Mexican Republic:: importance of the Cancer registry (a population-based study)
    Fajardo-Gutierrez, Arturo
    Juarez-Ocana, Servando
    Gonzalez-Miranda, Guadalupe
    Palma-Padilla, Virginia
    Carreon-Cruz, Rogelio
    Ortega-Alvarez, Manuel Carlos
    Mejia-Arangure, Juan Manuel
    [J]. BMC CANCER, 2007, 7 (1)
  • [6] Frequency of thiopurine S-methyltransferase mutant alleles in indigenous and admixed Guatemalan patients with acute lymphoblastic leukemia
    Garrido, Claudia
    Giron Santizo, Veronica
    Muellers, Petra
    Rigaud Soriano, Daphney
    Bendfeldt Avila, Giovana
    Dean, Michael
    Jimenez-Morales, Silvia
    [J]. MEDICAL ONCOLOGY, 2013, 30 (01)
  • [7] Methylation status of RB1 promoter in Indian retinoblastoma patients
    Joseph, B
    Mamatha, G
    Raman, G
    Shanmugam, MP
    Kumaramanickavel, G
    [J]. CANCER BIOLOGY & THERAPY, 2004, 3 (02) : 184 - 187
  • [9] Trends in childhood cancer incidence in the US (1992-2004)
    Linabery, Amy M.
    Ross, Julie A.
    [J]. CANCER, 2008, 112 (02) : 416 - 432
  • [10] Epigenetic and Copy Number Variation Analysis in Retinoblastoma by MS-MLPA
    Livide, Gabriella
    Epistolato, Maria Carmela
    Amenduni, Mariangela
    Disciglio, Vittoria
    Marozza, Annabella
    Mencarelli, Maria Antonietta
    Toti, Paolo
    Lazzi, Stefano
    Hadjistilianou, Theodora
    De Francesco, Sonia
    D'Ambrosio, Alfonso
    Renieri, Alessandra
    Ariani, Francesca
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2012, 18 (03) : 703 - 712